Mark J. Enyedy - Jun 11, 2021 Form 4 Insider Report for LogicBio Therapeutics, Inc. (LOGC)

Role: Director
Signature: /s/ Jonathan Quick, as Attorney-in-Fact
Stock symbol: LOGC
Transactions as of: Jun 11, 2021
Transactions value $: $0
Form type: 4
Date filed: 6/14/2021, 08:01 PM
Next filing: Jul 2, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	LOGC	Stock Option (right to buy)	Award	$0	+12.5K		$0.00	12.5K	Jun 11, 2021	Common Stock	12.5K	$4.59	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The options were granted by the Issuer pursuant to its 2018 Equity Incentive Plan as provided under the Company's compensation policy for non-employee directors. All of the options will vest and become exercisable on the earlier of (i) the first anniversary of the grant date, and (ii) the day prior to the Company's 2022 annual meeting of stockholders, subject to the Reporting Person's continuous service with the Issuer through the vesting date.

Content

The options were granted by the Issuer pursuant to its 2018 Equity Incentive Plan as provided under the Company's compensation policy for non-employee directors. All of the options will vest and become exercisable on the earlier of (i) the first anniversary of the grant date, and (ii) the day prior to the Company's 2022 annual meeting of stockholders, subject to the Reporting Person's continuous service with the Issuer through the vesting date.